Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis

Sheng, H; Wang, XL

Wang, XL (通讯作者),Yantai Shan Hosp, Dept Radiol, 91 Airport Rd, Yantai 264000, Shandong, Peoples R China.

ANTI-CANCER DRUGS, 2023; 34 (2): 214

Abstract

Cisplatin (DDP)-based chemotherapy is the main chemotherapeutic agent for ovarian cancer (OC) treatment. Circular RNA PIP5K1A (circ-PIP5K1A) was found......

Full Text Link